|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
4652420 |
| 003 |
ICU |
| 005 |
20031021135800.0 |
| 008 |
011203s2002 maua b 001 0 eng |
| 010 |
|
|
|a 2001050762
|
| 020 |
|
|
|a 079237620X (alk. paper)
|
| 035 |
|
|
|a 2001050762
|
| 040 |
|
|
|a DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC182.S4
|b S457 2002
|
| 082 |
0 |
0 |
|a 616.9/44
|2 21
|
| 245 |
0 |
4 |
|a The sepsis text /
|c edited by Jean-Louis Vincent, Jean Carlet, Steven M. Opal.
|
| 260 |
|
|
|a Boston :
|b Kluwer Academic Publishers,
|c c2002.
|
| 300 |
|
|
|a xx, 848 p. :
|b ill. ;
|c 24 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Introduction /
|r J. L. Vincent, J. Carlet and S. Opal --
|g 1.
|t Sepsis: The magnitude of the problem /
|r J. L. Vincent --
|g 2.
|t Diagnosis and source of sepsis: The utility of clinical findings /
|r K. Cruz and R. P. Dellinger --
|g 3.
|t Organ failure /
|r R. Moreno, R. Matos and T. Fevereiro --
|g 4.
|t Markers of sepsis /
|r H. Redl, A. Spittler and W. Strohmaier --
|g 5.
|t Genetic predisposition /
|r F. Stuber --
|g 6.
|t Quantifying risk in sepsis: A review of illness severity and organ dysfunction scoring /
|r R. S. Wax, D. C. Angus and W. Knaus --
|g 7.
|t The pathogenesis of Gram-negative sepsis /
|r C. Papasian and D. C. Morrison --
|g 8.
|t The pathophysiology of Gram-positive shock /
|r R. K. Beaton and J. Cohen --
|g 9.
|t Immunopathogenesis of Gram-negative shock /
|r S. M. Opal and C. E. Hubert --
|g 10.
|t Involvement of pro- and anti-inflammatory cytokines in sepsis /
|r J. M. Cavaillon and M. Adib-Conquy --
|g 11.
|t Pathophysiology of immunodepression in ICU patients /
|r H. D. Volk, C. Hoflich and G. Grutz /
|r [et al.] --
|g 12.
|t Pathophysiology of sepsis: the role of nitric oxide /
|r S. J. Finney and T. W. Evans --
|g 13.
|t Apoptosis and the resolution of inflammation in sepsis /
|r G. J. Bellingan --
|g 14.
|t Microvascular alterations in sepsis /
|r A. W. Sielenkamper, P. Kvietys and W. J. Sibbald --
|g 15.
|t Cytopathic hypoxia /
|r M. P. Fink --
|g 16.
|t Invasive hemodynamic monitoring /
|r E. Huettemann, S. G. Sakka and K. Reinhart --
|g 17.
|t Value of SvO[subscript 2] in sepsis /
|r T. Boulain and J. L. Teboul --
|g 18.
|t Blood lactate concentrations in sepsis /
|r J. A. Kruse --
|g 19.
|t Veno-arterial PCO[subscript 2] gradient /
|r V. Castelain and J. L. Teboul --
|g 20.
|t Gas tonometry /
|r E. Silva and L. F. Poli de Figueiredo --
|g 21.
|t General hemodynamic support /
|r S. M. Hollenberg --
|g 22.
|t Fluid administration /
|r A. R. Webb --
|g 23.
|t Blood transfusion and sepsis /
|r D. Neilipovitz and P. C. Hebert --
|g 24.
|t Catecholamine therapy /
|r C. Martin, J. F. Dasta and G. M. Susla --
|g 25.
|t Regional effects of catecholamines /
|r A. Meier-Hellmann --
|g 26.
|t Management of respiratory dysfunction in patients with severe sepsis /
|r G. S. Martin and G. R. Bernard --
|g 27.
|t The role of nutritional support in sepsis /
|r D. K. Heyland, J. K. Lukan and S. A. McClave --
|g 28.
|t The sources of sepsis /
|r C. Alberti and C. Brun-Buisson --
|g 29.
|t Catheter-related sepsis /
|r J. F. Timsit --
|g 30.
|t Control of the source of sepsis /
|r J. C. Marshall --
|g 31.
|t Empirical antibiotic therapy for patients with severe sepsis and septic shock /
|r P. Y. Bochud, M. P. Glauser and J. Carlet /
|r [et al.] --
|g 32.
|t Candida infections in the intensive care unit /
|r J. S. Solomkin, E. J. Anaissie and B. B. Albair --
|g 33.
|t Why, when and how to isolate ICU patients /
|r B. Rubinovitch, P. Eggimann and D. Pittet --
|g 34.
|t The lung in sepsis /
|r P. M. Suter --
|g 35.
|t The heart in sepsis /
|r B. Tavernier and A. Mebazaa --
|g 36.
|t The brain in sepsis /
|r B. Philips and D. Bennett --
|g 37.
|t The gut in sepsis /
|r B. Vallet --
|g 38.
|t The kidney in sepsis /
|r M. G. Vervloet, H. A. Piepot and A. B. J. Groeneveld --
|g 39.
|t The coagulation system in sepsis /
|r C. E. Hack --
|g 40.
|t Should fever be treated in sepsis? /
|r B. A. Cunha --
|g 41.
|t Anti-cytokine therapy /
|r E. Abraham --
|g 42.
|t Heat shock proteins and sepsis: A hot story /
|r J. Villar and A. S. Slutsky --
|g 43.
|t Immunodepression in the surgical patient and increased susceptibility to infection /
|r M. K. Angele and E. Faist --
|g 44.
|t The place of corticosteroids /
|r D. Annane and E. Bellissant --
|g 45.
|t The place of immunonutrition /
|r B. L. Zarzaur and K. A. Kudsk --
|g 46.
|t Interference with the coagulation system /
|r L. G. Thijs --
|g 47.
|t Hemofiltration and plasmapheresis /
|r P. Rogiers --
|g 48.
|t Endotoxin analogs in the treatment of septic shock /
|r M. E. Astiz --
|g 49.
|t Vaccines against bacterial endotoxins /
|r A. K. Bhattacharjee, A. S. Cross and S. M. Opal.
|
| 650 |
|
0 |
|a Septicemia.
|0 http://id.loc.gov/authorities/subjects/sh85120119
|
| 650 |
|
7 |
|a Septicemia.
|2 fast
|0 http://id.worldcat.org/fast/fst01112835
|
| 700 |
1 |
|
|a Vincent, J. L.
|0 http://id.loc.gov/authorities/names/n85022577
|1 http://viaf.org/viaf/73947492
|
| 700 |
1 |
|
|a Carlet, Jean.
|0 http://id.loc.gov/authorities/names/n92801548
|1 http://viaf.org/viaf/11509697
|
| 700 |
1 |
|
|a Opal, Steven M.
|0 http://id.loc.gov/authorities/names/n2001017157
|1 http://viaf.org/viaf/6735669
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)48557539
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 0c317606-93ba-5efc-9191-853fcbb287b1
|s d0282b45-71cb-5e5f-86ea-771321aaf312
|
| 928 |
|
|
|t Library of Congress classification
|a RC182.S4 S457 2002
|l JCL
|c JCL-Sci
|i 4542162
|
| 927 |
|
|
|t Library of Congress classification
|a RC182.S4 S457 2002
|l JCL
|c JCL-Sci
|e DOED
|e CRERAR
|b 60543728
|i 7260481
|
